Affiliation:
1. Department of Psychology, Indiana University Purdue University Fort Wayne (IPFW), Fort Wayne, IA
2. Department of Pathology, at University of Texas Southwestern Medical Center and Children's Health, Dallas, TX
3. Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX
Abstract
Abstract
BACKGROUND
Genetic information is unique among all laboratory data because it not only informs the current health of the specific person tested but may also be predictive of the future health of the individual and, to varying degrees, all biological relatives.
CONTENT
As DNA sequencing has become ubiquitous with decreasing cost, large repositories of genomic data have emerged from the domains of research, healthcare, law enforcement, international security, and recreational consumer interest (i.e., genealogy). Broadly shared genomic data are believed to be a key element for future discoveries in human disease. For example, the National Cancer Institute's Genomic Data Commons is designed to promote cancer research discoveries by providing free access to the genome data sets of 12000 cancer patients. However, in parallel with the promise of curing diseases, genomic data also have the potential for harm. Genomic data that are deidentified by standard healthcare practices (e.g., removal of name, date of birth) can be reidentified by methods that combine genomic software with publicly available demographic databases (e.g., phone book). Recent law enforcement cases (i.e., Bear Brook Murders, Golden State Killer) in the US have demonstrated the power of combining DNA profiles with genealogy databases.
SUMMARY
We examine the current environment of genomic privacy and confidentiality in the US and describe current and future risks to genomic privacy. Reidentification and inference of genetic information of biological relatives will become more important as larger databases of clinical, criminal, and recreational genomic information are developed over the next decade.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry, medical,Clinical Biochemistry
Reference42 articles.
1. Genetics for the identification of lipid targets beyond PCSK9;Wang;Can J Cardiol,2017
2. US Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. https://www.fda.gov/Drugs/ScienceResearch/ucm572698.htm (Accessed May 2018).
3. Regalado
A
. 2017 was the year consumer DNA testing blew up. MIT Technology Review. 2018Feb12. https://www.technologyreview.com/s/610233/2017-was-the-year-consumer-dna-testing-blew-up/ (Accessed May 2018).
4. Patients armed with their own genetic data raise tough questions;Storrs;Health Aff (Millwood),2018
5. Identifying personal genomes by surname inference;Gymrek;Science,2013
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献